CME: 0.5 credit

This podcast series from the Academy's Committee on Aging features leading experts who discuss clinical experiences and the differences in caring for older adults.

In today's podcast, Dr. Neil Bressler and colleagues consider the management of patients with diabetic macular edema (DME) and vision loss. Topics range from anti-VEGF therapy in older patients, including those unable to comply with a regular dosing regimen, to whether corticosteroids and focal laser still hold a place in the treatment protocol for DME.

Financial Disclosures: Dr. Drenser discloses an equity stake in FocusROP and Retinal Solutions and is a consultant to Synergetics. Dr. Pieramici is a consultant to Alimera, ThromboGenics, Genentech, Allergan, and Regeneron Pharmaceuticals. Dr. Bressler is a consultant to Abbott Medical Optics, Alimera Sciences, Allergan, Bausch & Lomb, Bristol-Myers Squibb, Carl Zeiss Meditec, DIAGNOS, ForSight Labs, Genentech, Genzyme, Lumenis, Notal Vision, Novartis, Pfizer, Regeneron Pharmaceuticals, Steba Biotech, EMMES Corporation, and ThromboGenics.

  Funded in part by the Retina Research Foundation

Review CME Activity Information

Take the posttest for CME credit